NCT01897415View on ClinicalTrials.gov

Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2017

Conditions
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Interventions
BIOLOGICAL

Autologous T cells transfected with chimeric anti-mesothelin immunoreceptor SS1

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01897415 - Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer | Biotech Hunter | Biotech Hunter